[Clinical Analysis on the Impact of Pretransplant Iron Overload on Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Acquired Severe Aplastic Anemia in Pediatric]

Overview

Journal Zhonghua Xue Ye Xue Za Zhi

Specialty Hematology

Date 2024 Aug 12

PMID 39134491

Authors

L Yan

H Xiong

F Long

Z Chen

Z Wang

L Yang

F Tao

Y Chen

N Song

M Wu

Affiliations

Soon will be listed here.

Abstract

This study aimed to investigate the effect of iron overload on the transplant outcomes of pediatric patients with severe aplastic anemia (SAA) undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT). A retrospective analysis was conducted on the clinical data of 74 children with SAA who received allo-HSCT at the Hematology Department of Wuhan Children's Hospital between January 2018 and August 2022. Children with iron overload (serum ferritin >1 000 μg/L) before transplantation had a longer disease course, received more red blood cell transfusions, and had a higher number of CD34(+) cells infused. Moreover, iron overload significantly delayed the reconstitution of regulatory T cells after transplantation, increasing the incidence of hemorrhagic cystitis and grade Ⅲ-Ⅳ acute graft-versus-host disease after transplantation. However, iron overload did not significantly affect the overall survival and failure-free survival rates of the children.

References

Xu L, Yu Y, Cheng Y, Zhang Y, Mo X, Han T . Development and validation of a mortality predicting scoring system for severe aplastic anaemia patients receiving haploidentical allogeneic transplantation. Br J Haematol. 2021; 196(3):735-742. DOI: 10.1111/bjh.17916. View

Salamonowicz-Bodzioch M, Fraczkiewicz J, Czyzewski K, Zajac-Spychala O, Gorczynska E, Panasiuk A . Prospective analysis of BKV hemorrhagic cystitis in children and adolescents undergoing hematopoietic cell transplantation. Ann Hematol. 2021; 100(5):1283-1293. PMC: 8043890. DOI: 10.1007/s00277-021-04454-7. View

Edinger M, Hoffmann P, Ermann J, Drago K, Fathman C, Strober S . CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation. Nat Med. 2003; 9(9):1144-50. DOI: 10.1038/nm915. View

Cattoni A, Capitoli G, Casagranda S, Corti P, Adavastro M, Molinaro A . Iron Overload Following Hematopoietic Stem Cell Transplantation: Prevalence, Severity, and Management in Children and Adolescents with Malignant and Nonmalignant Diseases. Transplant Cell Ther. 2023; 29(4):271.e1-271.e12. DOI: 10.1016/j.jtct.2023.01.020. View

Jin P, Wang J, Li X, Wang M, Ge M, Zhang J . Evolution of iron burden in acquired aplastic anemia: a cohort study of more than 3-year follow-up. Int J Hematol. 2014; 101(1):13-22. DOI: 10.1007/s12185-014-1708-6. View

Huang L, Fu R . [Research progress of characteristics and mechanisms of iron overload affecting bone marrow hematopoiesis]. Zhonghua Xue Ye Xue Za Zhi. 2019; 40(8):709-712. PMC: 7342874. DOI: 10.3760/cma.j.issn.0253-2727.2019.08.021. View

Huo Y, Pang A, Cheng T . [Advance in hematopoietic and immune reconstitution of allogeneic stem cell transplantation]. Zhonghua Xue Ye Xue Za Zhi. 2020; 41(11):958-963. PMC: 7767801. DOI: 10.3760/cma.j.issn.0253-2727.2020.11.018. View

Pan T, Ji Y, Liu H, Tang B, Song K, Wan X . Impact of Iron Overload and Iron Chelation with Deferasirox on Outcomes of Patients with Severe Aplastic Anemia after Allogeneic Hematopoietic Stem Cell Transplantation. Transplant Cell Ther. 2023; 29(8):507.e1-507.e8. DOI: 10.1016/j.jtct.2023.04.016. View

Georges G, Doney K, Storb R . Severe aplastic anemia: allogeneic bone marrow transplantation as first-line treatment. Blood Adv. 2018; 2(15):2020-2028. PMC: 6093726. DOI: 10.1182/bloodadvances.2018021162. View

10.

Franke G, Kubasch A, Cross M, Vucinic V, Platzbecker U . Iron overload and its impact on outcome of patients with hematological diseases. Mol Aspects Med. 2020; 75:100868. DOI: 10.1016/j.mam.2020.100868. View

11.

Wu Q, Zhou F, Song N, Liu X, Yu Z, Song X . [Clinical features and risk factors of hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation]. Zhonghua Xue Ye Xue Za Zhi. 2019; 40(3):187-190. PMC: 7342539. DOI: 10.3760/cma.j.issn.0253-2727.2019.03.004. View

12.

. [A Chinese expert panel consensus statement on diagnosis and treatment of iron overload]. Zhonghua Xue Ye Xue Za Zhi. 2012; 32(8):572-4. View

13.

Virtanen J, Itala-Remes M, Remes K, Vahlberg T, Saunavaara J, Sinisalo M . Prognostic impact of pretransplant iron overload measured with magnetic resonance imaging on severe infections in allogeneic stem cell transplantation. Eur J Haematol. 2013; 91(1):85-93. DOI: 10.1111/ejh.12123. View

14.

Dadwal S, Tegtmeier B, Liu X, Frankel P, Ito J, Forman S . Impact of pretransplant serum ferritin level on risk of invasive mold infection after allogeneic hematopoietic stem cell transplantation. Eur J Haematol. 2014; 94(3):235-42. DOI: 10.1111/ejh.12421. View

15.

. [Guidelines for the diagnosis and management of aplastic anemia in China (2022)]. Zhonghua Xue Ye Xue Za Zhi. 2023; 43(11):881-888. PMC: 9808872. DOI: 10.3760/cma.j.issn.0253-2727.2022.11.001. View

16.

Penack O, Marchetti M, Ruutu T, Aljurf M, Bacigalupo A, Bonifazi F . Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation. Lancet Haematol. 2020; 7(2):e157-e167. DOI: 10.1016/S2352-3026(19)30256-X. View

17.

Tayfun Kupesiz F, Hazar V, Eker N, Guler E, Yesilipek M, Tuysuz G . Retrospective Evaluation of Relationship Between Iron Overload and Transplantation Complications in Pediatric Patient Who Underwent Allogeneic Stem Cell Transplantation Due to Acute Leukemia and Myelodysplastic Syndrome. J Pediatr Hematol Oncol. 2020; 42(5):e315-e320. DOI: 10.1097/MPH.0000000000001829. View